%20and%20Batch%20Production%20Records%20(BPR).png)
Bergabunglah dengan Buletin Kami
Bergabunglah dengan daftar pelanggan kami untuk mendapatkan artikel terkini, update dan penawaran khusus langsung di kotak masuk Anda
Denali’s lead investigational TransportVehicle-enabled enzyme replacement therap...
Company expands presence in Southeast Asia with new regulatory clearances The ...
Dr Supriya Shidhaye outlines how the pharma industry can shrink emissions while...
Fourth edition recognises researchers across chemical and biological sciences c...
DCGI approval marks Cipla’s entry into orthobiologic medicine The post Cipla la...
Price band set at ₹1,008–₹1,062 per equity share The post Corona Remedies anno...
Early-stage deals account for majority of investment activity The post India ph...
Dr Suresh Saravdekar, former Assistant Director, Ministry of Medical Education ...
Granules India outlines the inspection outcome and operational role of its U.S....
The therapy is intended for patients who have undergone at least three previous ...
The approval enables the use of inavolisib in patients whose cancer has recurred...
The formulation will serve as a new administration route. Eisai’s application is...
The company will manufacture the product at its biotechnology facility in Pune, ...
This submission is the initial application for VIZZ under the exclusive licence ...
![<![CDATA[CGMs That Measure Alternative Biofluids Show Potential in Diabetes Care]]>](https://cdn.sanity.io/images/0vv8moc6/pharmacytimes/4b53ba72d33ffa47c1c93d2f252225dc0c944d03-6240x4160.jpg)
![<![CDATA[MRD, ctDNA Testing May Help Diagnose Multiple Myeloma Precursor Conditions]]>](https://cdn.sanity.io/images/0vv8moc6/pharmacytimes/8cdfabbbcee7b80457e18e1d1ec7395764cc6c99-5824x3264.jpg)
